The study “IL-1β-mediated activation of adipose-derived mesenchymal stromal cells results in PMN reallocation and enhanced phagocytosis. A possible mechanism for the reduction of osteoarthritis pathology” by the team of Stephanie C.M. van Dalen, Arjen B. Blom, Birgitte Walgreen, Annet W. Slöetjes, Monique M.A. Helsen, Edwin J.W. Geven, Thomas Vogl, Johannes Roth, Fons A.J. van de Loo, Marije I. Koenders, Louis Casteilla, Peter M. van der Kraan, Martijn H.J. van den Bosch, Peter L.E.M. van Lent was recently published in Frontiers in Immunology.
Learn more about ADIPOA-2 on the project website: www.adipoa2.eu
Follow the project on Twitter @adipoa2 and on Facebook https://www.facebook.com/adipoa2/
ADIPOA-2 has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 643809. The material presented and views expressed here are the responsibility of the author(s) only. The EU Commission takes no responsibility for any use made of the information set out.